With Peptides Booming, Rugiet Launches Physician-Prescribed Longevity Line

The men’s health company expands beyond testosterone and sexual health into NAD+, peptides, and recovery-focused longevity care

TL:DR

Rugiet is expanding into longevity, launching five physician-prescribed compounds — NAD+, Glutathione, Lipo-C, L-Carnitine, and Sermorelin — dispensed through a 503A compounding pharmacy with third-party purity testing.
The move targets the booming peptide gray market, where U.S. imports from China nearly doubled to $328 million in the first three quarters of 2025, per customs data cited by the company.
Rollout is in three phases: the initial compound launch, an optional biomarker lab offering for tracking results, and a future phase adding more prescribed peptides pending the FDA’s July ruling on peptide reclassification.

As we covered in our Peptides 101 breakdown, the peptide gray market has exploded and so have the risks. Unregulated research chemicals have flooded into the space with zero quality control, leaving athletes and everyday guys to gamble on sourcing.

So we commend Rugiet on what it is they’ve launched.

The performance medicine company, which has helped over 500,000 men address testosterone, sleep, and weight management, announced today it’s expanding into longevity treatments.

The new lineup includes NAD+, Glutathione, Lipo-C, L-Carnitine, and Sermorelin. All will be available via prescription, dispensed through a 503A compounding pharmacy, and third-party tested for purity.

Prescribed Longevity

For men and athletes looking for longevity or recovery help, quality is king. Rather than getting compounds, many of which have been quietly sourced from sketchy overseas suppliers, they are now available through a licensed-physician pathway with real testing and accountability behind them.

Each compound here addresses something Rugiet’s patients were already asking about, according to the company: energy, recovery, metabolic health, and how to stay strong as they age. NAD+ targets cellular energy directly, replenishing levels that naturally decline over time to support stamina and mental clarity. Glutathione backs the body’s defense against stress and supports immune function and recovery, while L-Carnitine helps move fatty acids into cells to be burned for fuel — useful for fat loss, endurance, and bouncing back from hard training. Sermorelin rounds out the lineup as the recovery-and-performance piece for men already on TRT, aimed at muscle performance and sleep quality.

Rugiet frames the timing around a gray market that’s grown faster than legitimate access can keep up with.

U.S. peptide imports from China nearly doubled to $328 million in the first three quarters of 2025, the company says, citing customs data; a surge it points to as evidence that unregulated operators are selling research-only chemicals with no quality control or accountability, and that demand for a physician-backed alternative has outpaced the options available.

“We saw a tremendous opportunity to create a higher standard for a category that desperately needs one,” said Mike Apostal, Rugiet’s CEO, framing the move as physician-led performance medicine rather than a wellness fad.

Co-Founder and Chief Medical Officer Dr. Vipul Khanpara emphasized that the new compounds went through the same internal vetting Rugiet applies across its full catalog, with each of the five earning a spot only after meeting the company’s qualification standards; a process he said the company won’t compromise on for any new offering.

The Bigger Picture

This expansion fits into Rugiet’s broader pitch. It wants to become a one-stop shop for men’s health, spanning sexual health, sleep, weight management, testosterone replacement, and now longevity — all under one physician-led roof.

What’s Coming

Rugiet’s rollout is happening in three phases.

Phase one is the five-compound launch above, available in injectable and nasal formats with personalized protocols.
Phase two adds an optional biomarker lab offering, giving patients a feedback loop to track whether their protocol is actually working.
Phase three brings additional prescribed peptides — pending the FDA’s advisory committee ruling on peptide reclassification, expected in July.

That FDA timeline is worth watching closely. Depending on how the reclassification shakes out, it could reshape access to several compounds currently sitting in regulatory limbo.

More info at rugiet.com/longevity.

Want the full breakdown on what peptides do, which ones are legit, and what could get you banned from competition? Check out our Peptides 101 guide.

About Rugiet
Since 2020, Rugiet has combined clinical authority with innovative, personalized treatments to help more than 500,000 men take control of their health. From sexual health and sleep, to weight management, testosterone and now longevity, we believe in not just fixing problems, but helping men optimize their health at every age. That’s performance medicine for men. Learn more at www.rugiet.com.